Pulications

Vaxlert: Peer-reviewed Vaccine Publications in Last Month

From Dec 01, 2024 To Dec 31, 2024 :

SARS-CoV-2 (COVID-19)

Humble RM, Lee JSW, Du C, Driedger SM, Dubé E, MacDonald SE. COVID-19 vaccine acceptance and preference for future delivery among language minority, newcomer, and racialized peoples in Canada: a national cross-sectional and longitudinal study Annals of medicine 57(1):2445777 2025 [PMID: 39729392]
Li B, Feng X, Zhang Y, Huang Y, Gu M, Sun H, Ren W, Zhen Q, Shen T, Pan L, Fan T, Qin Q, Liu F, Peng Y, Wang Y, Xu H. Effect of COVID-19 infection on thyroid function status and clinical indexes among hypothyroid outpatients Virulence 16(1):2441397 2025 [PMID: 39727211]
Li Z, Xiao F, Hou Y, Jia B, Zhuang J, Cao Y, Ma J, Zhao J, Xu Z, Jia Z, Liu F, Pang L, Liu J. Genomic epidemiology and evolution of Bordetella pertussis under the vaccination pressure of acellular vaccines in Beijing, China, 2020-2023 Emerging microbes & infections 14(1):2447611 2025 [PMID: 39725566]
Yang BF, Jin J, He XR, Yang ZH, Qian X, Tong YQ, Ke CX, Li ZH, Li ZX, Zhong LF, Gan ZH, Zhang XF, Zeng Y. Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial Expert review of vaccines 24(1):81-90 2025 [PMID: 39720838]
Priyambodo S, Kuo KC, Weng KP, Liu SF, Syu GD, Kuo HC. Neutralizing antibodies against SARS-CoV-2 of vaccinated healthcare workers in Taiwan Annals of medicine 57(1):2442533 2025 [PMID: 39711320]
Lei H, Niu B, Sun Z, Wang Y, Che X, Du S, Liu Y, Zhang K, Zhao S, Yang S, Wang Z, Zhao G. Influenza vaccine effectiveness against medically-attended influenza infection in 2023/24 season in Hangzhou, China Human vaccines & immunotherapeutics 21(1):2435156 2025 [PMID: 39704470]
Shembesh RH, Beshr MS, ALTarhouni MM. COVID-19 vaccine knowledge and acceptance among the Libyan population: A cross-sectional study Human vaccines & immunotherapeutics 21(1):2439590 2025 [PMID: 39701925]
Rungjirajittranon T, Nakkinkun Y, Suwanawiboon B, Chinthammitr Y, Owattanapanich W, Ruchutrakool T. Hemostatic changes following COVID-19 vaccination: Do they promote a pro-thrombotic state? Human vaccines & immunotherapeutics 21(1):2439627 2025 [PMID: 39699990]
Zheng Y, Wang D, Chen YT, Saxena K, Bencina G, Eiden AL. Trends in adolescent and adult vaccination in pharmacy and medical settings in the United States, 2018-2024: a database study Expert review of vaccines 24(1):53-66 2025 [PMID: 39676290]
Zheng X, Liu B, Ni P, Cai L, Shi X, Ke Z, Zhang S, Hu B, Yang B, Xu Y, Long W, Fang Z, Wang Y, Zhang W, Xu Y, Wang Z, Pan K, Zhou K, Wang H, Geng H, Hu H, Liu B. Development and application of an uncapped mRNA platform Annals of medicine 57(1):2437046 2025 [PMID: 39648715]
Al Akoury N, Spinardi J, Haridy H, Moussa M, Elshabrawi MA, Mendoza CF, Yang J, Dodd J, Kyaw MH, Yarnoff B. Modeling the potential public health and economic impact of different COVID-19 vaccination strategies with an adapted vaccine in the Kingdom of Saudi Arabia Expert review of vaccines 24(1):27-36 2025 [PMID: 39643949]
Miwa K. Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study eNeurologicalSci 38:100537 2025 [PMID: 39720104]
Wang J, Zhou H, Song W, Xu L, Zheng Y, You C, Zhang X, Peng Y, Wang X, Chen T. Evaluation of wastewater percent positive for assessing epidemic trends - A case study of COVID-19 in Shangrao, China Infectious Disease Modelling 10(1):325-337 2025 [PMID: 39649243]
Sodagari S, Sodagari N. Examining vaccination-related adverse events in frequent neurodegenerative diseases Brain, behavior, & immunity - health 43:100902 2025 [PMID: 39686920]
Fischer A, Peretti-Watel P, Ward J. Vaccine policies in France and Europe Current opinion in immunology 92:102513 2025 [PMID: 39675153]
Misselwitz F, Henderson D, Menakuru SR, Morten E, Roe C, Whitaker G, Wohlfeil S, McDermott J. Pharmacokinetics, Pharmacodynamics and Bioavailability of ACM-001.1 (S-Pindolol Benzoate) in Healthy Volunteers Journal of cachexia, sarcopenia and muscle 16(1):e13651 2025 [PMID: 39665235]
Limpoco MAA, Faes C, Hens N. Linear Mixed Modeling of Federated Data When Only the Mean, Covariance, and Sample Size Are Available Statistics in medicine 44(1-2):e10300 2025 [PMID: 39663139]
Liao J, Li C, Liu J, Cheng H, Li L, Tang G, Huang R, Lu Y, Chen S, Zhang Q, Chen H, Chen Q, Chen H, Sun D. Automatic and integrated detection of nucleic acid by using a dual-mode thermal controlled digital microfluidic chip Analytica chimica acta 1334:343415 2025 [PMID: 39638464]
Sahoo D, Atochina-Vasserman EN, Lu J, Maurya DS, Ona N, Vasserman JA, Ni H, Berkihiser S, Park WJ, Weissman D, Percec V. Toward a Complete Elucidation of the Primary Structure-Activity in Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers for In Vivo Delivery of Luc-mRNA Biomacromolecules 26(1):726-737 2025 [PMID: 39688403]
Smith J, Schrader S, Morgan H, Shenton P, Alafaci A, Cox N, Taylor AJ, Hare J, Jones B, Crawford NW, Buttery JP, Clothier HJ, Cheng DR. Clinical phenotype of COVID-19 vaccine-associated myocarditis in Victoria, 2021-22: a cross-sectional study The Medical journal of Australia 222(1):23-29 2025 [PMID: 39655683]
Spierings S, Oguoma VM, Shakeshaft A, Walker J, Toombs M, Ward JS. Knowledge about COVID-19 vaccines among Aboriginal and Torres Strait Islander people, and attitudes to and behaviours regarding COVID-19 and influenza vaccination: a survey The Medical journal of Australia 222(1):30-37 2025 [PMID: 39655627]
Marchese AM, Beyhaghi H, Rousculp MD, Huang V, Liu X, Toback S, Faust SN. Local and systemic reactogenicity after mRNA and protein-based COVID-19 vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomized phase 2 trial (COV-BOOST) Vaccine 44:126569 2025 [PMID: 39643572]
Filimonovic J, Stosic M, Gazibara T, Dotlic J, Joksimovic B, Subaric A, Stevanovic J, Radulovic A, Mijovic B, Subaric L, Kovacevic M, Radulovic J, Antonijevic A, Milic M. The trend in national childhood immunization program coverage throughout Serbian communities in Kosovo and Metohija from 2003 to 2022: pre-COVID-19 period vs. COVID-19 pandemic Vaccine 44:126576 2025 [PMID: 39643571]
Piché-Renaud PP, Drover SSM, Austin PC, Morris SK, Buchan SA, Nasreen S, Schwartz KL, Tadrous M, Thampi N, Wilson SE, Wilson K, Guttmann A, Kwong JC. COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study Vaccine 44:126539 2025 [PMID: 39617675]
Cosma C, Radi A, Cattano R, Zanobini P, Bonaccorsi G, Lorini C, Del Riccio M. Exploring Chatbot contributions to enhancing vaccine literacy and uptake: A scoping review of the literature Vaccine 44:126559 2025 [PMID: 39615346]
Flores D, Luna EM. The effectiveness of vaccines against COVID-19 in Mexico: A time series approach Vaccine 44:126565 2025 [PMID: 39615344]
Thiem VD, Anh DD, Ha VH, Van Thom N, Thang TC, Mateus J, Carreño JM, Raghunandan R, Huong NM, Mercer LD, Flores J, Escarrega EA, Raskin A, Thai DH, Van Be L, Sette A, Innis BL, Krammer F, Weiskopf D. Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial Vaccine 44:126542 2025 [PMID: 39615342]
Janes ME, Gottlieb AP, Park KS, Acharya S, Bibbey MG, Mitragotri S. Controlling vaccine kinetics using tannic acid for enhanced humoral immunity Journal of controlled release : official journal of the Controlled Release Society 379:135-146 2025 [PMID: 39733913]
Aljehani ND, Tamming L, Khan MY, Abdulal RH, Alfaleh MA, Ghazwani A, Helal A, Alsulaiman RM, Sanki MA, Alluhaybi K, Sukareh FA, Alharbi RH, Alyami FH, ElAssouli M-Z, Shebbo S, Abdulaal WH, Algaissi A, Mahmoud AB, Basabrain M, Duque D, Bavananthasivam J, Chen W, Wang L, Sauve S, Abujamel TS, Altorki T, Alhabbab R, Tran A, Li X, Hashem AM. Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animals mBio 16(1):e0217024 2025 [PMID: 39629990]
Zhu K, Sah M, Mahimainathan L, Liu Y, Xing C, Roush K, Clark A, SoRelle J. Prospective clinical performance of CoVarScan in identifying SARS-CoV-2 Omicron subvariants Microbiology spectrum 13(1):e0138524 2025 [PMID: 39660915]
Anglero-Rodriguez YI, Lempp FA, Subramanian M, McIninch J, Schlegel MK, Bohan D, Wong E, Brown CR, Foster DJ, Castoreno AB, Nguyen T, Cuffe D, Montiel-Ruiz M, Kaiser H, Sahakyan A, Spreafico R, Morskaya SS, Barry JD, Berman D, Zhang L, Lefebvre S, Kasper A, Racie T, Weddle D, Mobley M, Wassarman K, Bisbe A, Zlatev I, Rogers A, Nechev L, Dybowski J, Chong S, Nair J, Simon A, Sloan K, Hwang S, Virgin HW, Fitzgerald K, Maier MA, Hinkle G, Hebner CM, Akinc A, Jadhav V. High resistance barrier and prophylactic protection in preclinical models of SARS-CoV-2 with two siRNA combination Nucleic acids research 53(1) 2025 [PMID: 39657790]
Anderer S. CDC Recommends Second COVID-19 Vaccine Dose for Older Adults JAMA 333(1):12 2025 [PMID: 39641947]
Guo X, Yang S, Cai Z, Zhu S, Wang H, Liu Q, Zhang Z, Feng J, Chen X, Li Y, Deng J, Liu J, Li J, Tan X, Fu Z, Xu K, Zhou L, Chen Y. SARS-CoV-2 specific adaptations in N protein inhibit NF-κB activation and alter pathogenesis The Journal of cell biology 224(1) 2025 [PMID: 39680116]
Hamilton NB, Arns S, Shelley M, Bechis I, Shelley JC. Calculating Apparent pK(a) Values of Ionizable Lipids in Lipid Nanoparticles Molecular pharmaceutics 22(1):588-593 2025 [PMID: 39655829]
Wickline VB, Hall AS, Lavrisa R, McCook K, Woodcock M, Bani M, Strepparava MG, Russo S, Nowicki S. Facial occlusion with medical masks: Impacts on emotion recognition rates for emotion types and intensities Quarterly journal of experimental psychology (2006) :17470218241308569 2025 [PMID: 39660585]
Demir M, Duman N, Akten HS, Inan S, Okan K, Yildirim O, Karakus HS, Ozgur S, Goksel O. A rare long-term side effect of COVID-19 vaccines: Symmetrical drug-related intertriginous and flexural exanthema-like reaction SDRIFE and potential immunogens for delayed type hypersensitivity reactions International immunopharmacology 145:113737 2025 [PMID: 39642561]
García-Rivera D, Puga-Gómez R, Fernández-Castillo S, Paredes-Moreno B, Ricardo-Delgado Y, Rodríguez-González M, Silva CV, Pérez-Nicado R, Rodríguez-Noda L, Santana-Mederos D, Climent-Ruiz Y, Noa-Romero E, Cruz-Sui O, Sánchez-Ramírez B, Hernández-García T, Palenzuela-Diaz A, Martínez-Perez M, García-López A, Valdés-Balbín Y, Vérez-Bencomo VG. Safety and durability of the immune response after vaccination with the heterologous schedule of anti-COVID-19 vaccines SOBERANA®02 and SOBERANA® Plus in children 3-18 years old Vaccine: X 22:100595 2025 [PMID: 39737224]
van Ewijk CE, Suárez Hernández S, Jacobi RHJ, Knol MJ, Hahné SJM, Wijmenga-Monsuur AJ, Boer MC, van de Garde MDB. Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicity Vaccine: X 22:100593 2025 [PMID: 39734394]
Yuan M, Wilson IA. Structural Immunology of SARS-CoV-2 Immunological reviews 329(1):e13431 2025 [PMID: 39731211]
Nguyen JL, Mitratza M, Volkman HR, de Munter L, Tran TMP, Marques C, Mustapha M, Valluri S, Yang J, Antón A, Casas I, Conde-Sousa E, Drikite L, Grüner B, Icardi G, Ten Kate GL, Martin C, Mira-Iglesias A, Orrico-Sánchez A, Otero-Romero S, Rohde G, Jodar L, McLaughlin JM, Bollaerts K. Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform EClinicalMedicine 79:102995 2025 [PMID: 39726669]
Aschenbrenner DS. Updated COVID-19 vaccine for 2024-2025 respiratory virus season The American journal of nursing 125(1):21 2025 [PMID: 39723786]
Buonsenso D, Camporesi A, Sawaya C, Ulloa-Gutierrez R, Faugier-Fuentes E, Dueñas L, Paternina-de la Ossa RA, Llamas-Guillén BA, Gámez-González LB, Gálvez-Rafael N, Gatica A, Saltigeral-Simental P, Cuatecontzi-Romero A, Almeida FJ, Cuan S, Zapata-Yarlequé EH, Beltrán S, Reina-Bautista E, Collia A, Ivankovich-Escoto G, Fernández-Sarmiento J, Tremoulet AH. Impact of social determinants of health on the outcomes of Latin American children with Multisystem Inflammatory Syndrome (MIS-C) Pediatric pulmonology 60(1):e27313 2025 [PMID: 39723622]
Wu Q, Zhang B, Tong J, Bailey LC, Bunnell HT, Chen J, Chrischilles EA, Christakis DA, Downs SM, Hirabayashi K, Mishkin AD, Mosa ASM, Pajor NM, Rao S, Razzaghi H, Schwenk HT, Sills MR, Wang H, Wang L, Wang Y, Zhang D, Zhou T, Jhaveri R, Tchetgen Tchetgen EJ, Morris JS, Forrest CB, Chen Y. Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents EClinicalMedicine 79:102962 2025 [PMID: 39720603]
Rodriguez S, Haider K, Patel F, Thatigiri G, Pope B, Albana J, Daulat SR, Madhivanan P, Krupp K. Sociopolitical antecedents influencing COVID-19 vaccine uptake in Pima County, Arizona Vaccine: X 22:100589 2025 [PMID: 39719942]
Parlar YE, Gülnar MÖ, Kırmızıgül B, Gençdal G, Zeybel M, Keskin O, Yurdaydın C. The Course of COVID-19 Infection in Patients With Chronic Hepatitis Delta Journal of viral hepatitis 32(1):e14054 2025 [PMID: 39716764]
Kiti MC, Sacoor C, Aguolu OG, Zelaya A, Chen H, Kim SS, Cavele N, Jamisse E, Tchavana C, Jose A, Macicame I, Joaquim O, Ahmed N, Liu CY, Yildirim I, Nelson K, Jenness SM, Maldonado H, Kazi M, Srinivasan R, Mohan VR, Melegaro A, Malik F, Bardaji A, Omer SB, Lopman B. Social Contact Patterns in Rural and Urban Settings, Mozambique, 2021-2022 Emerging infectious diseases 31(1):94-9103 2025 [PMID: 39714303]
Ma J, Yang Y, Huang Y. Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990-2022 Emerging infectious diseases 31(1):14-21 2025 [PMID: 39714280]
Muayad J, Masood H, Alam Z, Loya A, Lee AG. Herpes zoster ophthalmicus temporally after COVID-19 vaccination: a systematic review of uncontrolled case reports and case series Proceedings (Baylor University. Medical Center) 38(1):69-75 2025 [PMID: 39712418]
Nakabembe E, Greenland M, Amaral K, Abu-Raya B, Amone A, Andrews N, Cantrell L, Lesne E, Gorringe A, Halkerston R, Mcstraw N, Dixon L, Hunter OF, Heath PT, Imede E, Kyohere M, Musoke P, Nakimuli A, Sekikubo M, Taylor S, Tusubira V, Sadarangani M, Le Doare K. Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda The Lancet. Global health 13(1):e81-e97 2025 [PMID: 39706666]
Rege S, Parlett LE, Neikirk A, Iizuka A, Yang Y, Huang C, Crystal S, Davidow A, Haynes K, Gerhard T, Rose CD, Strom BL, Horton DB. New Diagnoses of Juvenile Idiopathic Arthritis Early in the COVID-19 Pandemic: Analysis of a Large United States Commercial Insurance Database Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 31(1):40-44 2025 [PMID: 39705125]
Wei HY, Fan XJ, Mao MW. A Review on Circular RNA Translation and Its Implications in Disease Methods in molecular biology (Clifton, N.J.) 2883:109-137 2025 [PMID: 39702706]
Nath A, Kolson DL. Reemerging Infectious Diseases and Neuroimmunologic Complications Neurology(R) neuroimmunology & neuroinflammation 12(1):e200356 2025 [PMID: 39693583]
Alshamrani M, Farahat F, Albarrak A, El-Saed A, Shibl AM, Memish ZA, Mousa M, Haridy H, Althaqafi A. Narrative review of factors associated with SARS-CoV-2 coinfection in Middle Eastern countries and the need to vaccinate against preventable diseases Journal of infection and public health 18(1):102600 2025 [PMID: 39689411]
Mänd SÅ, Sjöholm Å. Ephemeral Diabetes After COVID-19 Vaccination JCEM case reports 3(1):luae228 2025 [PMID: 39678649]
Meslé MMI, Brown J, Widdowson MA, Pebody RG. Incorrect interpretation of the role of COVID-19 vaccination boosters in saving lives - Authors' reply The Lancet. Respiratory medicine 13(1):e5 2025 [PMID: 39675360]
De Bie T. Incorrect interpretation of the role of COVID-19 vaccination boosters in saving lives The Lancet. Respiratory medicine 13(1):e4 2025 [PMID: 39675359]
Scorza CA, Scorza FA, Finsterer J. New, late-onset relapsing-remitting multiple sclerosis in a woman in her 60s after SARS-CoV-2 vaccination Clinics (Sao Paulo, Brazil) 80:100556 2025 [PMID: 39674029]
Efe C, Uzun S, Matter MS, Terziroli Beretta-Piccoli B. Autoimmune-Like Hepatitis Related to SARS-CoV-2 Vaccination: Towards a Clearer Definition Liver international : official journal of the International Association for the Study of the Liver 45(1) 2025 [PMID: 39673711]
McElroy AK. In Vitro Evaluation of Bunyavirus T Cell Immunity Methods in molecular biology (Clifton, N.J.) 2893:137-150 2025 [PMID: 39671035]
Naqvi N, Ahuja Y, Zarin S, Alam A, Ali W, Shariq M, Hasnain SE, Ehtesham NZ. BCG's role in strengthening immune responses: Implications for tuberculosis and comorbid diseases Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 127:105703 2025 [PMID: 39667418]
Daungsupawong H, Wiwanitkit V. Sudden Sensorineural Hearing Loss Before COVID-19, During COVID-19, and After Inactivated Vaccination: Correspondence Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 46(1):118 2025 [PMID: 39666749]
Calvo-Silveria S, González-Díaz A, Marimón JM, Cercenado E, Quesada MD, Casabella A, Larrosa N, Berbel D, Alonso M, Bernat-Sole M, Saiz-Escobedo L, Yuste J, Martí S, Càmara J, Ardanuy C. Resilience and emergence of pneumococcal serotypes and lineages in adults post-PCV13 in Spain: A multicentre study Journal of infection and public health 18(1):102619 2025 [PMID: 39662160]
Mok CKP, Tang YS, Tan CW, Chong KC, Chen C, Sun Y, Yiu K, Ling KC, Chan KK, Hui DS. Comparison of safety and immunogenicity in the elderly after receiving either Comirnaty or Spikevax monovalent XBB1.5 COVID-19 vaccine The Journal of infection 90(1):106374 2025 [PMID: 39657850]
Deng Y, Wang CS, Cheng GD, Whitson JA, Dow BJ, Lee AY. The role of interdependent self-construal in mitigating the effect of conspiratorial beliefs on vaccine acceptance The British journal of social psychology 64(1):e12836 2025 [PMID: 39651836]
Morgan G, Fung CYJ, Gingras AC, Colwill K, Briollais L, Frangione E, Wolday D, Qi F, Pasculescu A, Delgado-Brand M, Mailhot G, Tursun T, Arnoldo S, Bearss E, Binnie A, Borgundvaag B, Casalino S, Chowdhary S, Dagher M, Devine L, Elliott LT, Friedman SM, Khan Z, Lapadula E, MacDonald G, Mazzulli T, McLeod SL, Mighton C, Nirmalanathan K, Richardson D, Stern S, Taher A, Young J, Lerner-Ellis J, Taher J. Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study Clinical biochemistry 135:110859 2025 [PMID: 39645018]
Schrell L, Fuchs HL, Dickmanns A, Scheibner D, Olejnik J, Hume AJ, Reineking W, Störk T, Müller M, Graaf-Rau A, Diederich S, Finke S, Baumgärtner W, Mühlberger E, Balkema-Buschmann A, Dobbelstein M. Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4'-fluorouridine Antiviral research 233:106046 2025 [PMID: 39638153]
Martin CA, Woolf K, Bryant L, Carr S, Gray LJ, Gupta A, Guyatt AL, John C, Melbourne C, McManus IC, Nazareth J, Nellums LB, Tobin MD, Pan D, Khunti K, Pareek M. Corrigendum to "Persistent hesitancy for SARS-CoV-2 vaccines among healthcare workers in the United Kingdom: analysis of longitudinal data from the UK-REACH cohort study" [The Lancet Regional Health - Europe, Volume 13, February 2022, 100299] The Lancet regional health. Europe 48:101148 2025 [PMID: 39634277]
Wahid L, Froess JD, Ortel TL, Zarychanski R, Berger JS, Cushman M, Angus DC, Renard V, Farahani P, Webb S, Heath A, Godoy LC, Farkouh ME, Hochman JS, Neal MD, Lawler PR. On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19 Arteriosclerosis, thrombosis, and vascular biology 45(1):162-164 2025 [PMID: 39633573]
Širvinskienė G, Norė A, Grincevičius J, Grincevičienė Š. Experiences of childbirth care among mothers in Lithuania during COVID-19 Infant mental health journal 46(1):46-58 2025 [PMID: 39627963]
Tian S, Chen Y, Su Q, Sun B, Lin Z, Long Y, Wang H, Liao C, Zhang Y, Zheng J, Chen L, Guan S, Wang S, Xu X, Ai J, Zhang W, Deng J. Pertussis clinical profile shift, severity, prediction in a tertiary hospital: A comparative study before, during, and after COVID-19 in Southern China Journal of infection and public health 18(1):102610 2025 [PMID: 39626401]
Georgakopoulou VE, Taskou C, Spandidos DA, Sarantaki A. Long COVID‑19 and pregnancy: A systematic review Biomedical reports 22(1):15 2025 [PMID: 39624781]
Ørbo HS, de Matos Kasahara T, Wolf AS, Bjørlykke KH, Sexton J, Jyssum I, Tveter AT, Solum G, Kjønstad IF, Bhandari S, Christensen IE, Kvien TK, Lind A, Kared H, Jahnsen J, Haavardsholm EA, Munthe LA, Provan SA, Vaage JT, Mjaaland S, Syversen SW, Jørgensen KK, Grødeland G, Goll GL. Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study The Lancet regional health. Europe 48:101121 2025 [PMID: 39624496]
Faliti CE, Van TTP, Anam FA, Cheedarla N, Williams ME, Mishra AK, Usman SY, Woodruff MC, Kraker G, Runnstrom MC, Kyu S, Sanz D, Ahmed H, Ghimire M, Morrison-Porter A, Quehl H, Haddad NS, Chen W, Cheedarla S, Neish AS, Roback JD, Antia R, Hom J, Tipton CM, Lindner JM, Ghosn E, Khurana S, Scharer CD, Khosroshahi A, Lee FE, Sanz I. Publisher Correction: Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE Nature immunology 26(1):148 2025 [PMID: 39622950]
Arai T, Inoue Y, Akasaka K, Masunaga A, Fujita M, Yamaguchi E, Saigusa M, Murakami K, Kurahara Y, Tsuyuguchi K, Suzuki T, Miyazaki Y, Bando M, Suda T. Severity and prognosis of COVID-19 complicated by autoimmune pulmonary alveolar proteinosis Respiratory investigation 63(1):20-26 2025 [PMID: 39615320]
Lisco G, De Tullio A, Matin M, Giagulli VA, Guastamacchia E, De Pergola G, Piazzolla G, Triggiani V. Update on andrological effects of SARS-CoV-2 infection and COVID-19: An overview review Andrology 2024 [PMID: 39737850]
Ward JK, Peretti-Watel P, Dubé E, Verger P, Attwell K. Context matters: How to research vaccine attitudes and uptake after the COVID-19 crisis Human vaccines & immunotherapeutics 20(1):2367268 2024 [PMID: 39693197]
Bin Abdulrahman K, Bin Abdulrahman A. Scrutinizing the COVID-19 vaccine safety debate Human vaccines & immunotherapeutics 20(1):2401646 2024 [PMID: 39693192]
Zhao C, Lei R, Liu S, Zhao M. Kounis syndrome following COVID-19 vaccination: Clinical manifestations, mechanisms and management Human vaccines & immunotherapeutics 20(1):2365496 2024 [PMID: 39693186]
Wang J, Wang Y, Li Y, Ma M, Xie Y, Zhang Y, Guo J, Shi J, Sun C, Chi H, Tang H, Ermakov V, Jiao M. Bibliometric and visual analyses of vaccine literacy research from 1982 to 2023 Human vaccines & immunotherapeutics 20(1):2363019 2024 [PMID: 39693185]
Ittefaq M, Vu HT, Zain A, Ramazan T, Kreps GL. Analysis of public opinion polls about COVID-19 vaccines: Theoretical and policy implications for vaccine communication and campaigns to address vaccine hesitancy Human vaccines & immunotherapeutics 20(1):2437921 2024 [PMID: 39687950]
Shinde V, Lombard Koen A, Hoosain Z, Archary M, Bhorat Q, Fairlie L, Lalloo U, Masilela MSL, Moodley D, Hanley S, Fouche LF, Louw C, Tameris M, Singh N, Goga A, Dheda K, Grobbelaar C, Joseph N, Lombaard JJ, Mngqibisa R, Bhorat AE, Benadé G, Lalloo N, Pitsi A, Vollgraaff PL, Luabeya A, Esmail A, Petrick FG, Oommen Jose A, Foulkes S, Ahmed K, Thombrayil A, Kalonji D, Cloney-Clark S, Zhu M, Bennett C, Albert G, Marcheschi A, Plested JS, Neal S, Chau G, Cho I, Fries L, Glenn GM, Madhi SA. Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M(TM) adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial Human vaccines & immunotherapeutics 20(1):2425147 2024 [PMID: 39666396]
Alpeza F, Avermark H, Gobbo E, Herzig van Wees S. How has co-design been used to address vaccine hesitancy globally? A systematic review Human vaccines & immunotherapeutics 20(1):2431380 2024 [PMID: 39660656]
Ber I, Na'amnih W, Perlman S, Kasstan B, Lerman Y, Muhsen K. Developing and validating a culturally tailored questionnaire to assess COVID-19 vaccine hesitancy in Israel's ultraorthodox Jewish population Human vaccines & immunotherapeutics 20(1):2429233 2024 [PMID: 39635713]
Maddeppungeng M, Nurdin A, Nency YM, Sekartini R, Medise BE, Soedjatmiko S, Massi MN, Darma S, Darussalam AHE, Ramadhani N, Hidayah N, Chalid MT, Ramadany S, Wahyuni S, Djaharuddin I, Santoso A, Fikri B, Alimuddin S, Pelupessy NM, Masadah R, Putri AZ, Setyaningsih L, Yani FF, Anggrainy F, Deza PA, Maharani N, Mahati E, Hapsari R, Farhanah N, Pramudo SG, Tri Anantyo D. Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, placebo-controlled phase 2 study Human vaccines & immunotherapeutics 20(1):2429231 2024 [PMID: 39632708]
Alghalyini B, Zia Zaidi AR, Zangiabadi S, Alamgir A, Tamim H. Vaccine hesitancy among Syrian refugee parents in Canada: A multifaceted challenge in public health Human vaccines & immunotherapeutics 20(1):2430086 2024 [PMID: 39618040]
Butt AIK, Ahmad W, Rabbani HG, Rafiq M, Ahmad S, Ahmad N, Malik S. Exploring optimal control strategies in a nonlinear fractional bi-susceptible model for Covid-19 dynamics using Atangana-Baleanu derivative Scientific reports 14(1):31617 2024 [PMID: 39738098]
Peroumal D, Jawale CV, Choi W, Rahimi H, Antos D, Li DD, Wang S, Manakkat Vijay GK, Mehta I, West R, Thangaraju M, Nolin TD, Das J, Alcorn JF, Biswas PS. The survival of B cells is compromised in kidney disease Nature communications 15(1):10842 2024 [PMID: 39738044]
Wang W, Chen K, Jiang T, Wu Y, Wu Z, Ying H, Yu H, Lu J, Lin J, Ouyang D. Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery Nature communications 15(1):10804 2024 [PMID: 39738043]
Yang J, Hong W, Shi H, He C, Lei H, Zhou Y, Yang H, Alu A, Chen Z, Yang Y, Yu W, Tang C, Wang J, Li B, Huang Q, Li J, Yang L, Wang W, Shen G, Yang J, Zhao Z, Song X, Su Z, Wei Y, Sun Q, Lu S, Wang Z, Wang Y, Lu G, Li W, Wei X. Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials Nature communications 15(1):10778 2024 [PMID: 39738039]
Yuson M, Bautista CT, Rees EM, Bogaardt C, Cruz VDD, Durrant R, Formstone A, Manalo DL, Manzanilla DR, Kundergorski M, Nacion L, Aloyon H, Bolivar JK, Bondoc J, Cobbold C, Panganiban E, Telmo SVM, Maestro J, Miranda MEG, Chng NR, Brunker K, Hampson K. Combining genomics and epidemiology to investigate a zoonotic outbreak of rabies in Romblon Province, Philippines Nature communications 15(1):10753 2024 [PMID: 39737920]
Almishrafi HA, Alhaqbani AA, Alshammari WI, Alqulaysh BF, Alnasyan AY, Alwadie SA, Almozini MA, Alghamdi MA, Alhqyal AS, Alhabi NY. Coverage of Recommended Vaccination Among Adult Patients With Asthma in Riyadh, Saudi Arabia Cureus 16(12):e76620 2024 [PMID: 39737110]
Zubaid AM, Alhamdi MT, Al-Harthi NI, Al-Harthi KM, AlQarni RA, Shebany YM, Fathelrahman AI, Abdelwahab SF. Confidence in the efficacy of routine vaccines after the COVID-19 pandemic: a cross-sectional web-based study BMC public health 24(1):3608 2024 [PMID: 39736559]
Lim CS, Sarver DE, Brown DC, McCulloh R, Malloch L, Gissandaner TD, Annett RD. Caregiver Willingness to Participate in Pediatric Clinical Research During COVID-19 Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners 2024 [PMID: 39736049]
Kuncorojakti S, Delaiah D, Aswin A, Puspitasari Y, Damayanti Y, Susilowati H, Diyantoro, Hamid IS, Al Arif MA, Suwarno, Rodprasert W. Development of peptone-based serum-free media to support Vero CCL-81 cell proliferation and optimize SARS-CoV2 viral production Heliyon 10(24):e41077 2024 [PMID: 39735625]
Alhasan KA, Raina R, Boyer O, Koh J, Bonilla-Felix M, Sethi SK, Amer YS, Coccia P, Temsah MH, Exantus J, Khan SA, Zhong X, Koch V, Duzova A, Vasudevan A, McCulloch M, Allen U, Filler G, Montini G. IPNA clinical practice recommendations on care of pediatric patients with pre-existing kidney disease during seasonal outbreak of COVID-19 Pediatric nephrology (Berlin, Germany) 2024 [PMID: 39733391]
Choi YJ, Jung J, Kang M, Choi MJ, Choi WS, Seo YB, Hyun HJ, Yoon Y, Choe YJ, Cho GJ, Kim YE, Kim DW, Seong H, Nham E, Yoon JG, Noh JY, Song JY, Kim WJ, Cheong HJ. Corrigendum to The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: propensity score-matched analysis with influenza vaccination Vaccine 46:126676 2024 [PMID: 39733480]
Jalilian H, Mohammadi P, Moradi A, Nikbina M, Sayfouri A, Birgani AN, Dehcheshmeh NF. Profession and role-based analysis of occupational exposure for COVID-19 among frontline healthcare workers in the pandemic: a risk assessment study Scientific reports 14(1):31253 2024 [PMID: 39732854]
Abounouh K, Tajudeen R, Majidi H, Redwane S, Laazaazia O, Aqillouch S, Ouma AEO, Abdulaziz M, Aragaw M, Fallah MP, Sembuche S, Batcho S, Kabwe P, Gonese E, Ainahi A, Sarih M, Kaseya J, Maaroufi A, Ezzikouri S. Immunologic assessment of the impact of SARS-CoV-2 vaccine booster doses on humoral immunity: a cross-sectional study in morocco BMC infectious diseases 24(1):1470 2024 [PMID: 39732651]
Lugano D, Kutima B, Kimani M, Sigilai A, Gitonga J, Karani A, Akech D, Karia B, Ziraba AK, Maina A, Lambisia A, Omuoyo D, Mugo D, Lucinde R, Owuor S, Konyino G, Newman J, Bailey D, Nduati E, Githinji G, Agoti CN, Bejon P, Scott JAG, Agweyu A, Kagucia W, Warimwe GM, Sande C, Ochola-Oyier LI, Nyagwange J. Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya BMC infectious diseases 24(1):1474 2024 [PMID: 39732637]
Siriratnam P, Chen Z, McArthur L, Reddell S, Zhang W, Buzzard K. The impacts of the COVID-19 pandemic on Australia's myasthenia gravis patients: A self-reported survey study Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2024 [PMID: 39730952]

See more by clicking HERE

Coronavirus

Humble RM, Lee JSW, Du C, Driedger SM, Dubé E, MacDonald SE. COVID-19 vaccine acceptance and preference for future delivery among language minority, newcomer, and racialized peoples in Canada: a national cross-sectional and longitudinal study Annals of medicine 57(1):2445777 2025 [PMID: 39729392]
Li B, Feng X, Zhang Y, Huang Y, Gu M, Sun H, Ren W, Zhen Q, Shen T, Pan L, Fan T, Qin Q, Liu F, Peng Y, Wang Y, Xu H. Effect of COVID-19 infection on thyroid function status and clinical indexes among hypothyroid outpatients Virulence 16(1):2441397 2025 [PMID: 39727211]
Yang BF, Jin J, He XR, Yang ZH, Qian X, Tong YQ, Ke CX, Li ZH, Li ZX, Zhong LF, Gan ZH, Zhang XF, Zeng Y. Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial Expert review of vaccines 24(1):81-90 2025 [PMID: 39720838]
Priyambodo S, Kuo KC, Weng KP, Liu SF, Syu GD, Kuo HC. Neutralizing antibodies against SARS-CoV-2 of vaccinated healthcare workers in Taiwan Annals of medicine 57(1):2442533 2025 [PMID: 39711320]
Lei H, Niu B, Sun Z, Wang Y, Che X, Du S, Liu Y, Zhang K, Zhao S, Yang S, Wang Z, Zhao G. Influenza vaccine effectiveness against medically-attended influenza infection in 2023/24 season in Hangzhou, China Human vaccines & immunotherapeutics 21(1):2435156 2025 [PMID: 39704470]
Shembesh RH, Beshr MS, ALTarhouni MM. COVID-19 vaccine knowledge and acceptance among the Libyan population: A cross-sectional study Human vaccines & immunotherapeutics 21(1):2439590 2025 [PMID: 39701925]
Rungjirajittranon T, Nakkinkun Y, Suwanawiboon B, Chinthammitr Y, Owattanapanich W, Ruchutrakool T. Hemostatic changes following COVID-19 vaccination: Do they promote a pro-thrombotic state? Human vaccines & immunotherapeutics 21(1):2439627 2025 [PMID: 39699990]
Zheng X, Liu B, Ni P, Cai L, Shi X, Ke Z, Zhang S, Hu B, Yang B, Xu Y, Long W, Fang Z, Wang Y, Zhang W, Xu Y, Wang Z, Pan K, Zhou K, Wang H, Geng H, Hu H, Liu B. Development and application of an uncapped mRNA platform Annals of medicine 57(1):2437046 2025 [PMID: 39648715]
Al Akoury N, Spinardi J, Haridy H, Moussa M, Elshabrawi MA, Mendoza CF, Yang J, Dodd J, Kyaw MH, Yarnoff B. Modeling the potential public health and economic impact of different COVID-19 vaccination strategies with an adapted vaccine in the Kingdom of Saudi Arabia Expert review of vaccines 24(1):27-36 2025 [PMID: 39643949]
Miwa K. Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study eNeurologicalSci 38:100537 2025 [PMID: 39720104]
Fischer A, Peretti-Watel P, Ward J. Vaccine policies in France and Europe Current opinion in immunology 92:102513 2025 [PMID: 39675153]
Limpoco MAA, Faes C, Hens N. Linear Mixed Modeling of Federated Data When Only the Mean, Covariance, and Sample Size Are Available Statistics in medicine 44(1-2):e10300 2025 [PMID: 39663139]
Liao J, Li C, Liu J, Cheng H, Li L, Tang G, Huang R, Lu Y, Chen S, Zhang Q, Chen H, Chen Q, Chen H, Sun D. Automatic and integrated detection of nucleic acid by using a dual-mode thermal controlled digital microfluidic chip Analytica chimica acta 1334:343415 2025 [PMID: 39638464]
Sahoo D, Atochina-Vasserman EN, Lu J, Maurya DS, Ona N, Vasserman JA, Ni H, Berkihiser S, Park WJ, Weissman D, Percec V. Toward a Complete Elucidation of the Primary Structure-Activity in Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers for In Vivo Delivery of Luc-mRNA Biomacromolecules 26(1):726-737 2025 [PMID: 39688403]
Smith J, Schrader S, Morgan H, Shenton P, Alafaci A, Cox N, Taylor AJ, Hare J, Jones B, Crawford NW, Buttery JP, Clothier HJ, Cheng DR. Clinical phenotype of COVID-19 vaccine-associated myocarditis in Victoria, 2021-22: a cross-sectional study The Medical journal of Australia 222(1):23-29 2025 [PMID: 39655683]
Spierings S, Oguoma VM, Shakeshaft A, Walker J, Toombs M, Ward JS. Knowledge about COVID-19 vaccines among Aboriginal and Torres Strait Islander people, and attitudes to and behaviours regarding COVID-19 and influenza vaccination: a survey The Medical journal of Australia 222(1):30-37 2025 [PMID: 39655627]
Marchese AM, Beyhaghi H, Rousculp MD, Huang V, Liu X, Toback S, Faust SN. Local and systemic reactogenicity after mRNA and protein-based COVID-19 vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomized phase 2 trial (COV-BOOST) Vaccine 44:126569 2025 [PMID: 39643572]
Filimonovic J, Stosic M, Gazibara T, Dotlic J, Joksimovic B, Subaric A, Stevanovic J, Radulovic A, Mijovic B, Subaric L, Kovacevic M, Radulovic J, Antonijevic A, Milic M. The trend in national childhood immunization program coverage throughout Serbian communities in Kosovo and Metohija from 2003 to 2022: pre-COVID-19 period vs. COVID-19 pandemic Vaccine 44:126576 2025 [PMID: 39643571]
Piché-Renaud PP, Drover SSM, Austin PC, Morris SK, Buchan SA, Nasreen S, Schwartz KL, Tadrous M, Thampi N, Wilson SE, Wilson K, Guttmann A, Kwong JC. COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study Vaccine 44:126539 2025 [PMID: 39617675]
Flores D, Luna EM. The effectiveness of vaccines against COVID-19 in Mexico: A time series approach Vaccine 44:126565 2025 [PMID: 39615344]
Thiem VD, Anh DD, Ha VH, Van Thom N, Thang TC, Mateus J, Carreño JM, Raghunandan R, Huong NM, Mercer LD, Flores J, Escarrega EA, Raskin A, Thai DH, Van Be L, Sette A, Innis BL, Krammer F, Weiskopf D. Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial Vaccine 44:126542 2025 [PMID: 39615342]
Aljehani ND, Tamming L, Khan MY, Abdulal RH, Alfaleh MA, Ghazwani A, Helal A, Alsulaiman RM, Sanki MA, Alluhaybi K, Sukareh FA, Alharbi RH, Alyami FH, ElAssouli M-Z, Shebbo S, Abdulaal WH, Algaissi A, Mahmoud AB, Basabrain M, Duque D, Bavananthasivam J, Chen W, Wang L, Sauve S, Abujamel TS, Altorki T, Alhabbab R, Tran A, Li X, Hashem AM. Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animals mBio 16(1):e0217024 2025 [PMID: 39629990]
Zhu K, Sah M, Mahimainathan L, Liu Y, Xing C, Roush K, Clark A, SoRelle J. Prospective clinical performance of CoVarScan in identifying SARS-CoV-2 Omicron subvariants Microbiology spectrum 13(1):e0138524 2025 [PMID: 39660915]
Anglero-Rodriguez YI, Lempp FA, Subramanian M, McIninch J, Schlegel MK, Bohan D, Wong E, Brown CR, Foster DJ, Castoreno AB, Nguyen T, Cuffe D, Montiel-Ruiz M, Kaiser H, Sahakyan A, Spreafico R, Morskaya SS, Barry JD, Berman D, Zhang L, Lefebvre S, Kasper A, Racie T, Weddle D, Mobley M, Wassarman K, Bisbe A, Zlatev I, Rogers A, Nechev L, Dybowski J, Chong S, Nair J, Simon A, Sloan K, Hwang S, Virgin HW, Fitzgerald K, Maier MA, Hinkle G, Hebner CM, Akinc A, Jadhav V. High resistance barrier and prophylactic protection in preclinical models of SARS-CoV-2 with two siRNA combination Nucleic acids research 53(1) 2025 [PMID: 39657790]
Guo X, Yang S, Cai Z, Zhu S, Wang H, Liu Q, Zhang Z, Feng J, Chen X, Li Y, Deng J, Liu J, Li J, Tan X, Fu Z, Xu K, Zhou L, Chen Y. SARS-CoV-2 specific adaptations in N protein inhibit NF-κB activation and alter pathogenesis The Journal of cell biology 224(1) 2025 [PMID: 39680116]
Demir M, Duman N, Akten HS, Inan S, Okan K, Yildirim O, Karakus HS, Ozgur S, Goksel O. A rare long-term side effect of COVID-19 vaccines: Symmetrical drug-related intertriginous and flexural exanthema-like reaction SDRIFE and potential immunogens for delayed type hypersensitivity reactions International immunopharmacology 145:113737 2025 [PMID: 39642561]
Yuan M, Wilson IA. Structural Immunology of SARS-CoV-2 Immunological reviews 329(1):e13431 2025 [PMID: 39731211]
Parlar YE, Gülnar MÖ, Kırmızıgül B, Gençdal G, Zeybel M, Keskin O, Yurdaydın C. The Course of COVID-19 Infection in Patients With Chronic Hepatitis Delta Journal of viral hepatitis 32(1):e14054 2025 [PMID: 39716764]
Kiti MC, Sacoor C, Aguolu OG, Zelaya A, Chen H, Kim SS, Cavele N, Jamisse E, Tchavana C, Jose A, Macicame I, Joaquim O, Ahmed N, Liu CY, Yildirim I, Nelson K, Jenness SM, Maldonado H, Kazi M, Srinivasan R, Mohan VR, Melegaro A, Malik F, Bardaji A, Omer SB, Lopman B. Social Contact Patterns in Rural and Urban Settings, Mozambique, 2021-2022 Emerging infectious diseases 31(1):94-9103 2025 [PMID: 39714303]
Ma J, Yang Y, Huang Y. Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990-2022 Emerging infectious diseases 31(1):14-21 2025 [PMID: 39714280]
Rege S, Parlett LE, Neikirk A, Iizuka A, Yang Y, Huang C, Crystal S, Davidow A, Haynes K, Gerhard T, Rose CD, Strom BL, Horton DB. New Diagnoses of Juvenile Idiopathic Arthritis Early in the COVID-19 Pandemic: Analysis of a Large United States Commercial Insurance Database Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 31(1):40-44 2025 [PMID: 39705125]
Wei HY, Fan XJ, Mao MW. A Review on Circular RNA Translation and Its Implications in Disease Methods in molecular biology (Clifton, N.J.) 2883:109-137 2025 [PMID: 39702706]
Alshamrani M, Farahat F, Albarrak A, El-Saed A, Shibl AM, Memish ZA, Mousa M, Haridy H, Althaqafi A. Narrative review of factors associated with SARS-CoV-2 coinfection in Middle Eastern countries and the need to vaccinate against preventable diseases Journal of infection and public health 18(1):102600 2025 [PMID: 39689411]
Efe C, Uzun S, Matter MS, Terziroli Beretta-Piccoli B. Autoimmune-Like Hepatitis Related to SARS-CoV-2 Vaccination: Towards a Clearer Definition Liver international : official journal of the International Association for the Study of the Liver 45(1) 2025 [PMID: 39673711]
Naqvi N, Ahuja Y, Zarin S, Alam A, Ali W, Shariq M, Hasnain SE, Ehtesham NZ. BCG's role in strengthening immune responses: Implications for tuberculosis and comorbid diseases Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 127:105703 2025 [PMID: 39667418]
Mok CKP, Tang YS, Tan CW, Chong KC, Chen C, Sun Y, Yiu K, Ling KC, Chan KK, Hui DS. Comparison of safety and immunogenicity in the elderly after receiving either Comirnaty or Spikevax monovalent XBB1.5 COVID-19 vaccine The Journal of infection 90(1):106374 2025 [PMID: 39657850]
Deng Y, Wang CS, Cheng GD, Whitson JA, Dow BJ, Lee AY. The role of interdependent self-construal in mitigating the effect of conspiratorial beliefs on vaccine acceptance The British journal of social psychology 64(1):e12836 2025 [PMID: 39651836]
Morgan G, Fung CYJ, Gingras AC, Colwill K, Briollais L, Frangione E, Wolday D, Qi F, Pasculescu A, Delgado-Brand M, Mailhot G, Tursun T, Arnoldo S, Bearss E, Binnie A, Borgundvaag B, Casalino S, Chowdhary S, Dagher M, Devine L, Elliott LT, Friedman SM, Khan Z, Lapadula E, MacDonald G, Mazzulli T, McLeod SL, Mighton C, Nirmalanathan K, Richardson D, Stern S, Taher A, Young J, Lerner-Ellis J, Taher J. Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study Clinical biochemistry 135:110859 2025 [PMID: 39645018]
Schrell L, Fuchs HL, Dickmanns A, Scheibner D, Olejnik J, Hume AJ, Reineking W, Störk T, Müller M, Graaf-Rau A, Diederich S, Finke S, Baumgärtner W, Mühlberger E, Balkema-Buschmann A, Dobbelstein M. Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4'-fluorouridine Antiviral research 233:106046 2025 [PMID: 39638153]
Širvinskienė G, Norė A, Grincevičius J, Grincevičienė Š. Experiences of childbirth care among mothers in Lithuania during COVID-19 Infant mental health journal 46(1):46-58 2025 [PMID: 39627963]
Tian S, Chen Y, Su Q, Sun B, Lin Z, Long Y, Wang H, Liao C, Zhang Y, Zheng J, Chen L, Guan S, Wang S, Xu X, Ai J, Zhang W, Deng J. Pertussis clinical profile shift, severity, prediction in a tertiary hospital: A comparative study before, during, and after COVID-19 in Southern China Journal of infection and public health 18(1):102610 2025 [PMID: 39626401]
Georgakopoulou VE, Taskou C, Spandidos DA, Sarantaki A. Long COVID‑19 and pregnancy: A systematic review Biomedical reports 22(1):15 2025 [PMID: 39624781]
Arai T, Inoue Y, Akasaka K, Masunaga A, Fujita M, Yamaguchi E, Saigusa M, Murakami K, Kurahara Y, Tsuyuguchi K, Suzuki T, Miyazaki Y, Bando M, Suda T. Severity and prognosis of COVID-19 complicated by autoimmune pulmonary alveolar proteinosis Respiratory investigation 63(1):20-26 2025 [PMID: 39615320]
Lisco G, De Tullio A, Matin M, Giagulli VA, Guastamacchia E, De Pergola G, Piazzolla G, Triggiani V. Update on andrological effects of SARS-CoV-2 infection and COVID-19: An overview review Andrology 2024 [PMID: 39737850]
Ward JK, Peretti-Watel P, Dubé E, Verger P, Attwell K. Context matters: How to research vaccine attitudes and uptake after the COVID-19 crisis Human vaccines & immunotherapeutics 20(1):2367268 2024 [PMID: 39693197]
Bin Abdulrahman K, Bin Abdulrahman A. Scrutinizing the COVID-19 vaccine safety debate Human vaccines & immunotherapeutics 20(1):2401646 2024 [PMID: 39693192]
Ittefaq M, Vu HT, Zain A, Ramazan T, Kreps GL. Analysis of public opinion polls about COVID-19 vaccines: Theoretical and policy implications for vaccine communication and campaigns to address vaccine hesitancy Human vaccines & immunotherapeutics 20(1):2437921 2024 [PMID: 39687950]
Shinde V, Lombard Koen A, Hoosain Z, Archary M, Bhorat Q, Fairlie L, Lalloo U, Masilela MSL, Moodley D, Hanley S, Fouche LF, Louw C, Tameris M, Singh N, Goga A, Dheda K, Grobbelaar C, Joseph N, Lombaard JJ, Mngqibisa R, Bhorat AE, Benadé G, Lalloo N, Pitsi A, Vollgraaff PL, Luabeya A, Esmail A, Petrick FG, Oommen Jose A, Foulkes S, Ahmed K, Thombrayil A, Kalonji D, Cloney-Clark S, Zhu M, Bennett C, Albert G, Marcheschi A, Plested JS, Neal S, Chau G, Cho I, Fries L, Glenn GM, Madhi SA. Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M(TM) adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial Human vaccines & immunotherapeutics 20(1):2425147 2024 [PMID: 39666396]
Ber I, Na'amnih W, Perlman S, Kasstan B, Lerman Y, Muhsen K. Developing and validating a culturally tailored questionnaire to assess COVID-19 vaccine hesitancy in Israel's ultraorthodox Jewish population Human vaccines & immunotherapeutics 20(1):2429233 2024 [PMID: 39635713]
Maddeppungeng M, Nurdin A, Nency YM, Sekartini R, Medise BE, Soedjatmiko S, Massi MN, Darma S, Darussalam AHE, Ramadhani N, Hidayah N, Chalid MT, Ramadany S, Wahyuni S, Djaharuddin I, Santoso A, Fikri B, Alimuddin S, Pelupessy NM, Masadah R, Putri AZ, Setyaningsih L, Yani FF, Anggrainy F, Deza PA, Maharani N, Mahati E, Hapsari R, Farhanah N, Pramudo SG, Tri Anantyo D. Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, placebo-controlled phase 2 study Human vaccines & immunotherapeutics 20(1):2429231 2024 [PMID: 39632708]
Alghalyini B, Zia Zaidi AR, Zangiabadi S, Alamgir A, Tamim H. Vaccine hesitancy among Syrian refugee parents in Canada: A multifaceted challenge in public health Human vaccines & immunotherapeutics 20(1):2430086 2024 [PMID: 39618040]
Butt AIK, Ahmad W, Rabbani HG, Rafiq M, Ahmad S, Ahmad N, Malik S. Exploring optimal control strategies in a nonlinear fractional bi-susceptible model for Covid-19 dynamics using Atangana-Baleanu derivative Scientific reports 14(1):31617 2024 [PMID: 39738098]
Peroumal D, Jawale CV, Choi W, Rahimi H, Antos D, Li DD, Wang S, Manakkat Vijay GK, Mehta I, West R, Thangaraju M, Nolin TD, Das J, Alcorn JF, Biswas PS. The survival of B cells is compromised in kidney disease Nature communications 15(1):10842 2024 [PMID: 39738044]
Wang W, Chen K, Jiang T, Wu Y, Wu Z, Ying H, Yu H, Lu J, Lin J, Ouyang D. Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery Nature communications 15(1):10804 2024 [PMID: 39738043]
Yang J, Hong W, Shi H, He C, Lei H, Zhou Y, Yang H, Alu A, Chen Z, Yang Y, Yu W, Tang C, Wang J, Li B, Huang Q, Li J, Yang L, Wang W, Shen G, Yang J, Zhao Z, Song X, Su Z, Wei Y, Sun Q, Lu S, Wang Z, Wang Y, Lu G, Li W, Wei X. Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials Nature communications 15(1):10778 2024 [PMID: 39738039]
Yuson M, Bautista CT, Rees EM, Bogaardt C, Cruz VDD, Durrant R, Formstone A, Manalo DL, Manzanilla DR, Kundergorski M, Nacion L, Aloyon H, Bolivar JK, Bondoc J, Cobbold C, Panganiban E, Telmo SVM, Maestro J, Miranda MEG, Chng NR, Brunker K, Hampson K. Combining genomics and epidemiology to investigate a zoonotic outbreak of rabies in Romblon Province, Philippines Nature communications 15(1):10753 2024 [PMID: 39737920]
Zubaid AM, Alhamdi MT, Al-Harthi NI, Al-Harthi KM, AlQarni RA, Shebany YM, Fathelrahman AI, Abdelwahab SF. Confidence in the efficacy of routine vaccines after the COVID-19 pandemic: a cross-sectional web-based study BMC public health 24(1):3608 2024 [PMID: 39736559]
Alhasan KA, Raina R, Boyer O, Koh J, Bonilla-Felix M, Sethi SK, Amer YS, Coccia P, Temsah MH, Exantus J, Khan SA, Zhong X, Koch V, Duzova A, Vasudevan A, McCulloch M, Allen U, Filler G, Montini G. IPNA clinical practice recommendations on care of pediatric patients with pre-existing kidney disease during seasonal outbreak of COVID-19 Pediatric nephrology (Berlin, Germany) 2024 [PMID: 39733391]
Jalilian H, Mohammadi P, Moradi A, Nikbina M, Sayfouri A, Birgani AN, Dehcheshmeh NF. Profession and role-based analysis of occupational exposure for COVID-19 among frontline healthcare workers in the pandemic: a risk assessment study Scientific reports 14(1):31253 2024 [PMID: 39732854]
Abounouh K, Tajudeen R, Majidi H, Redwane S, Laazaazia O, Aqillouch S, Ouma AEO, Abdulaziz M, Aragaw M, Fallah MP, Sembuche S, Batcho S, Kabwe P, Gonese E, Ainahi A, Sarih M, Kaseya J, Maaroufi A, Ezzikouri S. Immunologic assessment of the impact of SARS-CoV-2 vaccine booster doses on humoral immunity: a cross-sectional study in morocco BMC infectious diseases 24(1):1470 2024 [PMID: 39732651]
Lugano D, Kutima B, Kimani M, Sigilai A, Gitonga J, Karani A, Akech D, Karia B, Ziraba AK, Maina A, Lambisia A, Omuoyo D, Mugo D, Lucinde R, Owuor S, Konyino G, Newman J, Bailey D, Nduati E, Githinji G, Agoti CN, Bejon P, Scott JAG, Agweyu A, Kagucia W, Warimwe GM, Sande C, Ochola-Oyier LI, Nyagwange J. Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya BMC infectious diseases 24(1):1474 2024 [PMID: 39732637]
Mohammadi A, Chiang S, Li F, Wei F, Lau CS, Aziz M, Ibarrondo FJ, Fulcher JA, Yang OO, Chia D, Kim Y, Wong DTW. Direct detection of 4-dimensions of SARS-CoV-2: infection (vRNA), infectivity (antigen), binding antibody, and functional neutralizing antibody in saliva Scientific reports 14(1):30792 2024 [PMID: 39730575]
Madewell ZJ, Graff NE, Lopez VK, Rodriguez DM, Wong JM, Maniatis P, Medina FA, Muñoz JL, Briggs-Hagen M, Adams LE, Rivera-Amill V, Paz-Bailey G, Major CG. Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico Scientific reports 14(1):30743 2024 [PMID: 39730470]
Caetano C, Angeli L, Varela-Lasheras I, Coletti P, Morgado L, Lima P, Willem L, Nunes B, Hens N. Identifying the main drivers of transmission in the early phase of the COVID-19 pandemic in Portugal Scientific reports 14(1):30689 2024 [PMID: 39730359]
Kim TH, Bae S, Myoung J. Differential Impact of Spike Protein Mutations on SARS-CoV-2 Infectivity and Immune Evasion: Insights from Delta and Kappa Variants Journal of microbiology and biotechnology 34(12):2506-2515 2024 [PMID: 39631784]
Ali MA, Shaker OG, Ezzat EM, Ali ESG, Aboelor MI, Ahmed MI, Hassan EA, Ali DY, Ahmed HM, Khalefa AA, Hussein RA, Elkhateeb AF, Mohamed EA. Peripheral lncRNA NEAT-1, miR374b-5p, and IL6 panel to guide in COVID-19 patients' diagnosis and prognosis PloS one 19(12):e0313042 2024 [PMID: 39729489]
Dourdouna MM, Kourlaba G, Michos A. QuantiFERON SARS-CoV-2 assay for the evaluation of cellular immunity after immunization with mRNA SARS-CoV-2 vaccines: a systematic review and meta-analysis Immunologic research 73(1):25 2024 [PMID: 39729138]
Sechrist SJ, Tang E, Arnold BF, Acharya NR. Association between immunosuppressive medications and COVID-19 hospitalisation and death: a retrospective cohort study BMJ open 14(12):e087467 2024 [PMID: 39725432]
Vazquez-Alejo E, De La Sierra Espinar-Buitrago M, Magro-Lopez E, Tarancon-Diez L, Díez C, Bernardino JI, Rull A, De Los Santos I, Alonso R, Zamora A, Jiménez JL, Muñoz-Fernández MÁ. Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study Medical microbiology and immunology 214(1):4 2024 [PMID: 39724280]
Valderrama-Beltrán SL, Cuervo-Rojas J, Rondón M, Montealegre-Diaz JS, Vera JD, Martinez-Vernaza S, Bonilla A, Molineros C, Fierro V, Moreno A, Villalobos L, Ariza B, Álvarez-Moreno C. Development of a diagnostic multivariable prediction model of a positive SARS-CoV-2 RT-PCR result in healthcare workers with suspected SARS-CoV-2 infection in hospital settings PloS one 19(12):e0316207 2024 [PMID: 39724211]
Tarigan S, Sekarmila G, Apas, Sumarningsih, Tarigan R, Putri R, Setyawati DR. Challenges and strategies in the soluble expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD fusion proteins as candidates for COVID-19 intranasal vaccines PloS one 19(12):e0306153 2024 [PMID: 39724133]
Lee JH, Shin Y, Shin K-S, Park JY, Kim MS, Park Y-S, Kim W, Song JY, Noh JY, Cheong HJ, Kang C-Y, Seo SH, Kim J-O, Kim DR, Hwang NS, Yang JS, Kim JH, Shim B-S, Song M. Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults mSphere :e0099824 2024 [PMID: 39723823]
Li K, Hu X, Tu XY, Xian MY, Huang LL, Huang T, Luo R, Jin H, Liu Z. Enhancing COVID-19 Vaccine Efficacy: Dual Adjuvant Strategies with TLR7/8 Agonists and Glycolipids Journal of medicinal chemistry 67(24):21916-21933 2024 [PMID: 39648985]
Zhang C, Li F, Yu X, Tian H, Li Y, Liu X, Liu W, Yu B, Qiao ZA, Yu X. Periodic mesoporous organosilica-loaded mincle agonists enhance the immunogenicity of COVID-19 subunit vaccines by dual activation of B cells and dendritic cells Acta biomaterialia 2024 [PMID: 39730102]
Ezigbo ED, Enitan SS, Adejumo EN, Durosinmi AE, Akele RY, Dada MO, Itodo GE, Idoko AM, Edafetanure-Ibeh OM, Okafor EN, Abdulsalam AA, Oyedoyin OI, Yelpoji PU, Opeyemi OO, Nmesomachi OS, Oyekale AO, Onyeji CB. Acceptance of COVID-19 vaccine and its related determinants in Nigeria: An online survey World journal of virology 13(4):98551 2024 [PMID: 39722760]
IJspeert H, Edwards ESJ, O'Hehir RE, Dalm VASH, van Zelm MC. Update on inborn errors of immunity The Journal of allergy and clinical immunology 2024 [PMID: 39724969]
Lyukmanova EN, Pichkur EB, Nolde DE, Kocharovskaya MV, Manuvera VA, Shirokov DA, Kharlampieva DD, Grafskaia EN, Svetlova JI, Lazarev VN, Varizhuk AM, Kirpichnikov MP, Shenkarev ZO. Structure and dynamics of the interaction of Delta and Omicron BA.1 SARS-CoV-2 variants with REGN10987 Fab reveal mechanism of antibody action Communications biology 7(1):1698 2024 [PMID: 39719448]
Jing S, Xue L, Li X, Zeng F, Yang J. Age-structured modeling of COVID-19 dynamics: the role of treatment and vaccination in controlling the pandemic Journal of mathematical biology 90(1):12 2024 [PMID: 39718598]
Grin PM, Baid K, de Jesus HCR, Kozarac N, Bell PA, Jiang SZ, Kappelhoff R, Butler GS, Leborgne NGF, Pan C, Pablos I, Machado Y, Vederas JC, Kim H, Benarafa C, Banerjee A, Overall CM. SARS-CoV-2 3CL(pro) (main protease) regulates caspase activation of gasdermin-D/E pores leading to secretion and extracellular activity of 3CL(pro) Cell reports 43(12):115080 2024 [PMID: 39673710]
Chao CW, Sprouse KR, Miranda MC, Catanzaro NJ, Hubbard ML, Addetia A, Stewart C, Brown JT, Dosey A, Valdez A, Ravichandran R, Hendricks GG, Ahlrichs M, Dobbins C, Hand A, McGowan J, Simmons B, Treichel C, Willoughby I, Walls AC, McGuire AT, Leaf EM, Baric RS, Schäfer A, Veesler D, King NP. Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV Cell reports 43(12):115036 2024 [PMID: 39644492]
Ahn B, Shin SH, Hwang MJ, Choi H, Na S, Park S, Lee JS, Choe YJ, Yoon Y, Seo K, Kim JH, Kang HM. Epidemiological Characteristics and Outcome of Myocarditis and Pericarditis Temporally Associated With BNT162b2 COVID-19 Vaccine in Adolescents: Korean National Surveillance Journal of Korean medical science 39(49):e317 2024 [PMID: 39716863]
Abraham AA, Tan ZC, Shrestha P, Bozich ER, Meyer AS. A multivalent binding model infers antibody Fc species from systems serology PLoS computational biology 20(12):e1012663 2024 [PMID: 39715286]
Schmidt A, Casadei N, Brand F, Demidov G, Vojgani E, Abolhassani A, Aldisi R, Butler-Laporte G, Alawathurage TM, Augustin M, Bals R, Bellinghausen C, Berger MM, Bitzer M, Bode C, Boos J, Brenner T, Cornely OA, Eggermann T, Erber J, Feldt T, Fuchsberger C, Gagneur J, Göpel S, Haack T, Häberle H, Hanses F, Heggemann J, Hehr U, Hellmuth JC, Herr C, Hinney A, Hoffmann P, Illig T, Jensen BO, Keitel V, Kim-Hellmuth S, Koehler P, Kurth I, Lanz AL, Latz E, Lehmann C, Luedde T, Maj C, Mian M, Miller A, Muenchhoff M, Pink I, Protzer U, Rohn H, Rybniker J, Scaggiante F, Schaffeldt A, Scherer C, Schieck M, Schmidt SV, Schommers P, Spinner CD, Vehreschild MJGT, Velavan TP, Volland S, Wilfling S, Winter C, Richards JB, Heimbach A, Becker K, Ossowski S, Schultze JL, Nürnberg P, Nöthen MM, Motameny S, Nothnagel M, Riess O, Schulte EC, Ludwig KU. Systematic assessment of COVID-19 host genetics using whole genome sequencing data PLoS pathogens 20(12):e1012786 2024 [PMID: 39715278]
Bagala I, Namuganga JF, Nayebare P, Cuu G, Katairo T, Nabende I, Gonahasa S, Nassali M, Tukwasibwe S, Dorsey G, Nankabirwa JI, Bakeera-Kitaka S, Kiguli S, Greenhouse B, Ssewanyana I, Kamya MR, Briggs J. Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: A serial cross-sectional study PloS one 19(12):e0312554 2024 [PMID: 39715211]
Wasim R, Sumaiya, Ahmad A. Across-the-board review on Omicron SARS-CoV-2 variant Inflammopharmacology 2024 [PMID: 39714724]
Olivares-Caro L, Nova-Baza D, Sanhueza F, Contreras H, Alarcón B, Alarcon-Zapata P, Mennickent D, Duran D, Bustamante L, Perez AJ, Enos D, Vergara C, Mardones C. Targeted and untargeted cross-sectional study for sex-specific identification of plasma biomarkers of COVID-19 severity Analytical and bioanalytical chemistry 2024 [PMID: 39714519]
Soto Mas F, Zhao S, Ji M. Vaccine Intention, Uptake, and Hesitancy Among US Certified Food Producers: The National COVID-19 Organic Farmer Study Disaster medicine and public health preparedness 18:e321 2024 [PMID: 39711031]
Mészner Z, Lakatos B, Ludwig E. [Prevention of Streptococcus pneumoniae infections in adults] Orvosi hetilap 165(51):2008-2014 2024 [PMID: 39709573]
Cianci R, Caldarelli M, Rio P, Pignataro G, Sacco Fernandez M, Ocarino F, Della Polla DA, Franceschi F, Gasbarrini A, Gambassi G, Candelli M. Outcomes of Patients with Heart Failure Hospitalized for COVID-19-A Study in a Tertiary Italian Center Diseases (Basel, Switzerland) 12(12) 2024 [PMID: 39727667]
Chen S, Zhang Y, Ashuo A, Song S, Yuan L, Wang W, Wang C, Du Z, Wu Y, Tan D, Huang C, Chen J, Li Y, Bai J, Guo H, Huang Z, Guan Y, Xia N, Yuan Z, Zhang J, Yuan Q, Fang Z. Combination of spatial transcriptomics analysis and retrospective study reveals liver infection of SARS-COV-2 is associated with clinical outcomes of COVID-19 EBioMedicine 111:105517 2024 [PMID: 39709771]
Makan-Murphy N, Madhi SA, Dangor Z. Safety, Efficacy, and Effectiveness of Maternal Vaccination against Respiratory Infections in Young Infants Seminars in respiratory and critical care medicine 2024 [PMID: 39708836]
Kosiorek P, Mikołuć B, Stróż S, Hryniewicz A, Kazberuk DE, Milewski R, Grzeszczuk A, Borkowska MJ, Stasiak-Barmuta A. COVID-19-sensitive tumour response: 2-year assessment of the SARS-CoV-2 humoral response in cancer patients in oncology hospital in Poland Cancer immunology, immunotherapy : CII 74(1):27 2024 [PMID: 39708120]
Schlegtendal A, Maier C, Stein J, Höpner J, Petersmann A, Drinka D, Berner R, Lücke T, Toepfner N, Brinkmann F. Post-coronavirus disease 2019-associated symptoms among children and adolescents in the SARS-CoV-2 Omicron era European journal of pediatrics 184(1):96 2024 [PMID: 39707044]
Hiban K, Mabila SL, Murray JH, McQuistan AA, Wells NY. Post-acute sequelae of SARS-CoV-2 and kidney events in U.S. active component service members, March 1, 2020-September 30, 2022 MSMR 31(12):17-22 2024 [PMID: 39736159]
Rycen J, Jefferis J, Mudge D. Acute kidney injury and tacrolimus toxicity in a kidney transplant recipient treated with nirmaltrevir/ritonavir: a case report Journal of medical case reports 18(1):629 2024 [PMID: 39707559]
Hirano H, Asada H. Exponential decline, ceiling effect, downregulation, and T-cell response in immunoglobulin G antibody levels after messenger RNA vaccine boosters: a case report Journal of medical case reports 18(1):631 2024 [PMID: 39707550]
Endawkie A, Daba C, Asmare L, Desye B, Mawugatie TW, Melak D, Tsega Y. Trends of socioeconomic and geographic inequalities in COVID-19 vaccine uptake in Ethiopia: using the WHO Health Equity Assessment Toolkit BMC health services research 24(1):1629 2024 [PMID: 39707307]
Ramirez SI, Lopez PG, Faraji F, Parikh UM, Heaps A, Ritz J, Moser C, Eron JJ, Wohl D, Currier J, Daar ES, Greninger A, Klekotka P, Grifoni A, Weiskopf D, Sette A, Peters B, Hughes MD, Chew KW, Smith DM, Crotty S. Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2 JCI insight 9(24) 2024 [PMID: 39704169]
Maïga A, Bougma M, Wilson E, Kaboré TS, Tou GG, Munos MK, Kanté AM, Jiwani SS, Zack K, Akum A, Walker N, Black RE, Amouzou A. Effects of the COVID-19 pandemic on maternal, newborn, and child health service coverage in Burkina Faso Journal of global health 14:05037 2024 [PMID: 39700386]
Rudzite AM, Auzina D, Lejniece S. FACTORS AFFECTING COVID-19 OUTCOMES IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES Experimental oncology 46(3):260-267 2024 [PMID: 39704454]

See more by clicking HERE

** Click HERE to see the latest publications in this month.